Higher endoscopist polyp detection rates are significantly associated with fewer negative colonoscopies after positive stool tests, suggesting the need for new detection benchmarks, researchers say.

INDIANAPOLIS – Screening for colorectal cancer presents a unique opportunity unavailable for most other types of cancers. Screening allows for the detection of both precancerous polyps and cancer, ...

SAN DIEGO — For patients with a positive fecal immunochemical test, the risk for colorectal cancer increases if diagnostic colonoscopy is delayed beyond 6 months, according to new research. "In breast ...

Stool-based DNA testing can help bridge CRC screening gaps between rural and urban populations by providing timely follow-up. The study found no significant difference in follow-up times for ...

A study of 316,443 patients shows that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend, and of those who repeated home tests, over half ...

Patients with an average risk for colorectal cancer (CRC) are candidates for noninvasive tests, such as multitarget stool DNA (mtsDNA), whereas those with a higher risk, including those with a family ...

Since the early 2000s, CRC mortality has significantly decreased, largely due to advancements in screening and the removal of precancerous polyps. However, CRC continues to be the second most common ...